879 related articles for article (PubMed ID: 33511432)
1. Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities.
Orad RI; Shiner T
J Neurol; 2022 Feb; 269(2):639-653. PubMed ID: 33511432
[TBL] [Abstract][Full Text] [Related]
2. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
Duka V; Lee JH; Credle J; Wills J; Oaks A; Smolinsky C; Shah K; Mash DC; Masliah E; Sidhu A
PLoS One; 2013; 8(9):e75025. PubMed ID: 24073234
[TBL] [Abstract][Full Text] [Related]
3. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.
van Steenoven I; Majbour NK; Vaikath NN; Berendse HW; van der Flier WM; van de Berg WDJ; Teunissen CE; Lemstra AW; El-Agnaf OMA
Mov Disord; 2018 Nov; 33(11):1724-1733. PubMed ID: 30440090
[TBL] [Abstract][Full Text] [Related]
5. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
Jellinger KA; Korczyn AD
BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
[TBL] [Abstract][Full Text] [Related]
6. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U
J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836
[TBL] [Abstract][Full Text] [Related]
7. PD and DLB: Brain imaging in Parkinson's disease and dementia with Lewy bodies.
Berman SB; Miller-Patterson C
Prog Mol Biol Transl Sci; 2019; 165():167-185. PubMed ID: 31481162
[TBL] [Abstract][Full Text] [Related]
8. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Compta Y; Parkkinen L; O'Sullivan SS; Vandrovcova J; Holton JL; Collins C; Lashley T; Kallis C; Williams DR; de Silva R; Lees AJ; Revesz T
Brain; 2011 May; 134(Pt 5):1493-1505. PubMed ID: 21596773
[TBL] [Abstract][Full Text] [Related]
9. Metals in Alzheimer's and Parkinson's Disease: Relevance to Dementia with Lewy Bodies.
McAllum EJ; Finkelstein DI
J Mol Neurosci; 2016 Nov; 60(3):279-288. PubMed ID: 27498879
[TBL] [Abstract][Full Text] [Related]
10. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
Jellinger KA
J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
[TBL] [Abstract][Full Text] [Related]
11. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
[TBL] [Abstract][Full Text] [Related]
12. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
Spillantini MG; Goedert M
Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
[TBL] [Abstract][Full Text] [Related]
13. Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.
Lee SH; Cho H; Choi JY; Lee JH; Ryu YH; Lee MS; Lyoo CH
Mov Disord; 2018 Feb; 33(2):262-272. PubMed ID: 29168583
[TBL] [Abstract][Full Text] [Related]
14. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease with dementia, lewy-body disorders and alpha-synuclein: recent advances and a case report.
Wu CK
Acta Neurol Taiwan; 2011 Mar; 20(1):4-14. PubMed ID: 21560084
[TBL] [Abstract][Full Text] [Related]
16. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies.
Mosimann UP; Müri RM; Burn DJ; Felblinger J; O'Brien JT; McKeith IG
Brain; 2005 Jun; 128(Pt 6):1267-76. PubMed ID: 15774501
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
[TBL] [Abstract][Full Text] [Related]
18. Review: Clinical, neuropathological and genetic features of Lewy body dementias.
Hansen D; Ling H; Lashley T; Holton JL; Warner TT
Neuropathol Appl Neurobiol; 2019 Dec; 45(7):635-654. PubMed ID: 30977926
[TBL] [Abstract][Full Text] [Related]
19. Convergence of pathology in dementia with Lewy bodies and Alzheimer's disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease.
Winslow AR; Moussaud S; Zhu L; Post KL; Dickson DW; Berezovska O; McLean PJ
Brain; 2014 Jul; 137(Pt 7):1958-70. PubMed ID: 24860142
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and neuropathological characteristics of dementia with Lewy bodies].
Bencze J; Simon V; Bereczki E; Majer R; Varkoly G; Murnyák B; Kálmán J; Hortobágyi T
Orv Hetil; 2017 Apr; 158(17):643-652. PubMed ID: 28434243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
